Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy

American Journal of Gastroenterology

Volumn 92, Issue 12 SUPPL., 1997, Pages 2225-2229

  Heikkinen, Markku ^a   Janatuinen, Esko ^b   Mayo, Kathryn ^b   Mégraud, Francis ^b   Julkunen, Risto ^b   Pikkarainen, Pekka ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CELIAC DISEASE; DRUG USE; DYSPEPSIA; ESOPHAGITIS; GASTRITIS; GASTROSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; PATIENT SELECTION; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH CANCER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELIAC DISEASE; DYSPEPSIA; ESOPHAGITIS; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PEPTIC ULCER; REFERRAL AND CONSULTATION;

EID: 0030776962     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Axon ATR, Bell GD, Jones RH, et al. Guidelines on appropriate indications for upper gastrointestinal endoscopy. BMJ 1995;310:853-6.
2. Brown C, Rees WDW. Dyspepsia in general practice: Try empirical treatment first and investigate patients who do not respond. BMJ 1990;300:829-30.
3. 2-blocker therapy or prompt endoscopy in the management of dyspepsia. Lancet 1994;343:811-6.
4. Collins JSA, Bamford KB, Sloan JM, et al. Screening for Helicobacter pylori antibody could reduce endoscopy workload in young dyspeptic patients. Eur J Gastroenterol Hepatol 1992;4:991-3.
5. Mendall MA, Jazrawi RP, Marrero JM, et al. Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut 1995;36:330-3.
6. Sobala GM, Crabtree JE, Pentith JA, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991;338:94-6.
7. Tham TCK, McLaughlin N, Hughes DF, et al. Possible role of Helicobacter pylori serology in reducing endoscopy workload. Postgrad Med J 1994;70:809-12.
8. Vyas SK, Sharpstone D, Treasure J, et al. Pre-endoscopy screening using serodiagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994;6:783-5.
9. Covacci A, Lange N, Censini S, et al. The CAGI pathogenicity island of Helicobacter pylori. In: Hunt RH, Tytgat GNJ. Helicobacter pylori: Basic mechanism to clinical cure. Dozdzecht: Kluwer-Dordrect, 1996, 40-9.
10. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein: Peptic ulceration and gastric pathology. Lancet 1991;338:332-5.
11. Labigne A, Lamouliatte H, Birac C, et al. Distribution of the CagA gene among Helicobacter pylori strains associated with peptic ulcer. Am J Gastroenterol 1994;89:8 (abstract 166).
12. Lage AP, Godfroid E, Fauconnier A, et al. Frequency of CagA in Helicobacter pylori strains isolated from Belgian and Moroccan patients. Gut 1995;37:A69 (abstract 273).
13. Heikkinen M, Pikkarainen P, Takala J, et al. Etiology of dyspepsia: Four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995;30:519-23.
14. Colin-Jones DG, Bloom B, Bodemar G, et al. Management of dyspepsia: Report of a working party. Lancet 1988;1:576-9.
15. Feldman RA, Deeks JJ, Evans SJW, et al. Multi-laboratory comparison of eight commercial available Helicobacter pylori serology kits. Eur J Clin Microbiol Infect Dis 1995;14:428-33.
16. Xiang Z, Bugnoli M, Ponzetto A, et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993;12:739-45.
17. Burnette WN. Western blotting: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein. Anal Biochem 1981;56:480-8.
18. Tytgat GNJ, Anker Hansen J, Carling L, et al. Effect of cisapride on relapse of reflux oesophagitis healed with an antisecretory drug. Scand J Gastroenterol 1992;27:175-83.
19. Walker-Smith JA, Guandalini S, Schmitz J, et al. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 1990;65:909-11.
20. Oberhuber G, Kastner N, Stolte M. Giardiasis: A histologic analysis of 567 cases. Scand J Gastroenterol 1997;32:48-51.
21. EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
22. Crabtree JE, Wyatt JI, Sobala GM, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993; 34:1339-43.
23. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95:903-12.
24. Hillman AL, Bloom BS, Fendrick AM, et al. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. Arch Intern Med 1992;152:1467-72.
25. Schindlbeck NE, Klauser AG, Berghammer G, et al. Three year follow up of patients with gastroesophaaeal reflux disease. Gut 1992;33: 1016-9.